Dexmedetomidine sedation leading to refractory cardiogenic shock
- PMID: 18499610
- DOI: 10.1213/ane.0b013e318172fafc
Dexmedetomidine sedation leading to refractory cardiogenic shock
Abstract
Dexmedetomidine is frequently used for deep sedation during electrophysiology procedures. We report a case where, presumably, the use of dexmedetomidine resulted in a patient's death. The patient developed unexplained and refractory cardiogenic shock and could not be resuscitated. Autopsy failed to demonstrate any abnormality or cause of death. We postulate that, in certain susceptible individuals, dexmedetomidine may lead to terminal complications. We therefore urge caution about using dexmedetomidine in the electrophysiology laboratory.
Comment in
-
Expecting the unexpected.Anesth Analg. 2008 Jun;106(6):1605-6. doi: 10.1213/ane.0b013e31816c3f69. Anesth Analg. 2008. PMID: 18499586 No abstract available.
-
Dexmedetomidine sedation (and cardiac perforation, pericardial tamponade, cardiac arrest, and cardiopulmonary resuscitation) leading to refractory cardiogenic shock.Anesth Analg. 2009 Jan;108(1):379-80. doi: 10.1213/ane.0b013e31818c0d06. Anesth Analg. 2009. PMID: 19095881 No abstract available.
-
Caution is necessary when dexmedetomidine is used off-label, especially when combined with other sedatives.Anesth Analg. 2009 Jan;108(1):380-1; author reply 381-2. doi: 10.1213/ane.0b013e31818c0dac. Anesth Analg. 2009. PMID: 19095883 No abstract available.
-
Dexmedetomidine and refractory cardiogenic shock.Anesth Analg. 2009 Jan;108(1):380. doi: 10.1213/ane.0b013e31818c0d98. Anesth Analg. 2009. PMID: 19095884 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical